Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02796040 : Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.
PhaseN/A
AgesMin: 18 Years Max: 85 Years
Eligibility
Inclusion Criteria:

- Parkinson's disease (UK Parkinson's Disease Society Brain Bank Criteria)

- from 18 to 85 years old

- Impulse control disorder (one item ICD ?2 at the scale ECMP : Evaluation
Comportementale de la maladie de Parkinson)

Exclusion Criteria:

- Dementia (Mini Mental State < 26 or MATTIS < 130)

- Apathy (LARS (Lille Apathy Rating Scale) > 7)

- Depression (MADRS (Montgomery and Alsberg Depression Scale) ?16

- Contra indication to MRI (claustrophobia, deep brain stimulation, pace maker…)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02796040      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740